Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06166095 · ClinicalTrials.gov registry record · NA

Dose-Response Effect Exercise and Depression

A NA study of Depression, sponsored by University of Central Florida.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06166095: Completed NA study of Depression, sponsored by University of Central Florida.

NCT06166095 is a NA study of Depression that has completed, run by University of Central Florida. The registered enrollment target is 48 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06166095, a NA study of Depression, has completed, sponsored by University of Central Florida.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The present study aims to address gaps in the literature by evaluating the objectively measured dose-response relationship between exercise and depression symptoms; examining changes in resting (Brain-derived Neurotrophic Factor) BDNF from baseline to week 10 of an exercise intervention; and assessing varying exercise intensities on enjoyment, affect, and health-related quality of life in sedentary young adult college students.

Conditions Studied

Interventions

  • OTHER high-dose
  • OTHER Walking attention control
  • OTHER moderate-dose

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2023-07-01
Est. Completion 2024-12-01
Phase NA

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT06166095

The ClinicalTrials.gov registry entry for NCT06166095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which high-dose is the first listed.

NCT06166095 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06166095 about?

NCT06166095 is a clinical study titled "Dose-Response Effect Exercise and Depression". The present study aims to address gaps in the literature by evaluating the objectively measured dose-response relationship between exercise and depression symptoms; examining changes in resting (Brain-derived Neurotrophic Factor) BDNF from baseline to week 10 of an exercise intervention; and assessi...

What is the current status of trial NCT06166095?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2023-07-01. Estimated completion is 2024-12-01.

What conditions does trial NCT06166095 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT06166095?

The interventions under investigation include: high-dose (OTHER), Walking attention control (OTHER), moderate-dose (OTHER).

Who is sponsoring clinical trial NCT06166095?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06166095 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.